TwinsUK
TwinsUK[edit]
TwinsUK is a comprehensive research resource and cohort study based in the United Kingdom, focusing on the study of twins to understand the genetic and environmental influences on complex traits and diseases. Established in 1992, TwinsUK is one of the largest twin registries in the world, comprising over 14,000 identical and non-identical twins.
History[edit]
TwinsUK was founded by Professor Tim Spector at King's College London. The registry was initially created to study the heritability of osteoarthritis and other musculoskeletal disorders. Over the years, the scope of research has expanded to include a wide range of chronic diseases, genetic epidemiology, and epigenetics.
Research Focus[edit]
The primary aim of TwinsUK is to explore the genetic and environmental determinants of complex traits and diseases. The study covers a broad spectrum of health-related topics, including:
TwinsUK utilizes a variety of research methods, including genome-wide association studies (GWAS), epigenetic analyses, and metabolomics.
Contributions to Science[edit]
TwinsUK has significantly contributed to the understanding of the genetic basis of complex traits. The study has led to the discovery of numerous genetic variants associated with diseases such as type 2 diabetes, coronary artery disease, and rheumatoid arthritis.
The cohort has also been instrumental in advancing the field of epigenetics, providing insights into how environmental factors can influence gene expression and contribute to disease.
Collaborations[edit]
TwinsUK collaborates with numerous international research projects and consortia, including the International Human Epigenome Consortium and the Global Microbiome Conservancy. These collaborations enhance the study's ability to conduct large-scale analyses and validate findings across different populations.
Data and Resources[edit]
TwinsUK provides a rich resource of phenotypic and genotypic data, which is available to researchers worldwide. The data includes detailed health questionnaires, biological samples, and imaging data.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
